Long-term outcomes of regenerative spine care center on durable pain reduction, preserved spinal motion, and avoidance of major surgery. Published cohorts of intra-annular fibrin injection patients show an 83% success rate at long-term follow-up, with VAS pain scores dropping from 72.4mm baseline to 33.0mm at 104 weeks. Individual outcomes vary.
Key Takeaways
- Long-term tracking of the procedure spans more than 13,000 nationally-performed cases.
- 83% success rate in the long-term follow-up cohort (7,000+ tracked patients).
- VAS pain scores fell from 72.4mm baseline to 33.0mm at 104 weeks.
- Patient satisfaction at 2+ years has been reported at 70%.
- Among the most-tracked outcomes, individual results vary.
What This Guide Covers
- What does “long-term” mean in this context?
- What does the published data show?
- What does living with the results look like?
- How is durable benefit sustained?
What does “long-term” mean in this context?
Long-term in spine care research means follow-up at 2 years and beyond. Published data on the procedure includes 104-week follow-up showing durable benefit. The clinical record now spans 13,000+ procedures performed nationally, with 7,000+ tracked through long-term follow-up.
What does the published data show?
VAS pain scores in the published cohort fell from 72.4mm baseline to 33.0mm at 104 weeks. Patient satisfaction at 2+ year follow-up has been reported at 70%. Among the post-fusion subgroup, 80% of patients with prior failed surgery reported positive outcomes after the fibrin procedure. These are population-level statistics; individual outcomes vary.
What does living with the results look like?
For patients who respond well, the most reported gains are durable pain reduction, return to work and physical activity, and improved sleep. Most do not describe the procedure as a cure. They describe it as the intervention that gave them back room to live and eliminated the path toward fusion.
How is durable benefit sustained?
Durable benefit is sustained through ongoing rehab, posture and ergonomic discipline, and avoidance of the load patterns that contributed to the original lesion. Patients who treat the procedure as the start of a long-term spine-care plan tend to hold their gains better than patients who treat it as a one-time fix.
Clinical Note
“Getting back to life” is the phrase patients use more than any other when they describe what the procedure delivered for them. It is also the metric our clinical staff cares about most. Pain scores matter, satisfaction scores matter, but the question we ask at every long-term follow-up is whether the patient is living the way they wanted to live. Most patients in the long-term cohort answer yes, with caveats. The Valor team treats those caveats as honest data — life after disc-related pain is rarely as if the pain never happened. It is a return to the activities and relationships the pain had eroded.
Frequently Asked Questions
Do the results last forever?
The published 104-week data show durable benefit at two years. Spine care is lifelong; periodic check-ins and rehab maintenance support continued outcomes.
Can the same disc tear again later?
Re-injury is possible but uncommon when rehab and posture habits are maintained. New lesions at adjacent levels are a separate consideration over time.
Are these outcomes representative of all patients?
Outcomes vary. The published cohort is large, but each patient’s anatomy, history, and adherence to rehab influence individual results.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
